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Abstract: Genetic code expansion (GCE) has become a central topic of synthetic biology. GCE relies on engineered aminoacyl-tRNA synthetases 
(aaRSs) and a cognate tRNA species to allow codon reassignment by co-translational insertion of non-canonical amino acids (ncAAs) into pro-
teins. Introduction of such amino acids increases the chemical diversity of recombinant proteins endowing them with novel properties. Such 
proteins serve in sophisticated biochemical and biophysical studies both in vitro and in vivo, they may become unique biomaterials or thera-
peutic agents, and they afford metabolic dependence of genetically modified organisms for biocontainment purposes. In the Methanosarci-
naceae the incorporation of the 22nd genetically encoded amino acid, pyrrolysine (Pyl), is facilitated by pyrrolysyl-tRNA synthetase (PylRS) and 
the cognate UAG-recognizing tRNAPyl. This unique aaRStRNA pair functions as an orthogonal translation system (OTS) in most model organisms. 
The facile directed evolution of the large PylRS active site to accommodate many ncAAs, and the enzyme’s anticodon-blind specific recognition of 
the cognate tRNAPyl make this system highly amenable for GCE purposes. The remarkable polyspecificity of PylRS has been exploited to incorporate 
>100 different ncAAs into proteins. Here we review the Pyl-OT system and selected GCE applications to examine the properties of an effective OTS. 
 





EW macromolecular functions often come from the 
expansion of chemical diversity. In the field of syn-
thetic biology, the increase in chemical complexity origi-
nates from a functional demand. Using the genetic code 
expansion approach, non-canonical amino acids can be incor-
porated into proteins to study various biological phenomena 
and allow creation of new biomaterials and entire organisms.[1] 
Non-canonical amino acids include all amino acids that arose 
from genetic code expansion either naturally (such as seleno-
cysteine or pyrrolysine)[2] or were added to the genetic code 
via genetic code expansion (GCE) experiments. 
Translation With Standard and  
Non-canonical Amino Acids  
Twenty natural amino acids ubiquitously serve as building 
blocks for protein synthesis. Each amino acid is first covalently 
attached to its cognate tRNA by a specific aaRS. An elongation 
factor then binds aminoacyl-tRNA and delivers it to the 
ribosome, where the amino acid becomes incorporated into a 
nascent polypeptide chain in response to an assigned codon 
(Figure 1). Of the 64 triplet codons, 61 sense codons are 
assigned to a specific standard AA, while 3 stop codons signal 
for polypeptide chain termination mediated by release factors. 
 A genomic code expansion approach to introduce 
ncAAs in vivo involves site-specific co-translational incorpo-
ration through stop codon suppression (SCS, Figure 1). The 
targeted protein is expressed from an mRNA template con-
taining an internal stop codon reassigned for the ncAA. A 
ncAA specific aaRS aminoacylates its cognate tRNA devoted 
to decoding a stop codon (e.g. tRNAPylCUA for recognizing 
the UAG codon). Such a suppressor tRNA aminoacylated 
with the ncAA competes with release factors for the 
binding to the stop codon at the ribosome. If the 
suppressor tRNA is able to outcompete the release factors, 
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 Suppressor tRNA and aaRS dedicated to ncAA incor-
poration should not cross-react with host aaRSs, tRNAs or 
activate canonical amino acids. This lack of cross-reactivity 
defines the ncAA-specific aaRStRNA as orthogonal (o-pair 
or orthogonal translation system, OTS).  
The Best Orthogonal Translation 
Systems 
The success of ncAA incorporation strongly depends on the 
efficiency of the orthogonal aaRStRNA pair. The efficiency 
of each o-pair is determined by its inherent or engineered 
orthogonality, the ability of the aaRS to recognize the cog-
nate suppressor tRNA, and the malleability of the tRNA syn-
thetase active site. In addition to the orthogonal aaRStRNA 
pair, factors such as intracellular availability of the ncAA, 
the sequence context of the targeted codon in the RNA and 
any effect the incorporated ncAA may have on the recom-
binant protein’s folding also influence the ncAA incorpora-
tion efficiency. 
 To date, the majority of ncAA incorporation in Esch-
erichia coli and mammalian cells has been achieved by em-
ploying the Methanocaldococcus jannaschii TyrRStRNATyr 
or Methanosarcina mazei/Methanosarcina barkeri 
PylRStRNAPyl o-pairs.[1a] The latter is also amenable for use 
in Saccharomyces cerevisiae, while the E. coli Tyr-OTS pro-
vides a better choice than M. jannaschii Tyr-OTS[3] in yeast 
due to the lack of orthogonality of the archaeal o-pair in S. 
cerevisiae. Other notable examples for genetic code  
expansion experiments in E. coli include S. cerevisiae 
AspRStRNAAsp, GlnRStRNAGln, TyrRStRNATyr and 
PheRStRNAPhe o-pairs. Archaeal O-phosphoseryl-tRNA syn-
thetase (SepRS), a rare synthetase devoted to attaching 
phosphoserine (Sep) onto tRNACys as a precursor in Cys-
tRNACys synthesis has also been exploited for GCE pur-
poses.[4] The small number of OTSs developed that are not 
based on the Tyr- and Pyl-OTS and the even lower number of 
ncAAs that these OTSs can incorporate reflects the rigidity of 
aaRSs with respect to recognizing cognate AAs. This is 
evident by the relative difficulty of modifying the often used 
archaeal TyrRS beyond the spectrum of Tyr or Phe analogs.[1a]  
 
The PylRStRNAP yl System 
Pyrrolysyl-tRNA Synthetase 
PylRS is a homodimeric enzyme that catalyzes the for-
mation of PyltRNAPylCUA. Formation of Pyl-tRNAPyl follows 
the two step mechanism common to all aaRSs: Pyl is first 
activated with ATP to form a pyrrolysyl-adenylate (Pyl-
AMP) and then transferred to the 3′-hydroxyl group of the 
tRNAPyl terminal adenosine.[5] 
 Each monomer of PylRS can be roughly divided into 
its N-terminal and C-terminal portions, which are encoded 
by a single gene in the Methanosarcinaceae species or by 2 
separate genes in Desulfitobacterium hafniense (pylSn and 
pylSc, respectively).[6] Biochemical analysis of the N-termi-
nal D. hafniense PylRS fragment demonstrate its role in 
tRNA binding;[6] this is further supported by the lack of in 
vivo enzyme activity after truncation of the N-terminal 
PylRS domain.[7] A structural understanding of the role of 
the N-terminal domain of PylRS is lacking, as it does not 
have sequence homology with any known protein domain 
and its low solubility impedes production for crystallization 
purposes.  
 While the structure of the N-terminal domain is still 
unknown, the PylRS C-terminal domain structures have 
 
Figure 1. Schematic representation of stop codon suppression strategy. PylRS aminoacylates an orthogonal suppressor tRNA 
(anticodon CUA) with a non-cognate amino acid (ncAA). NcAA-tRNAPylCUA is delivered to the ribosome by the host elongation 
factor EF-Tu. At the ribosome, the ncAA-tRNAPylCUA decodes an internal stop codon (UAG) and the ncAA becomes incorporated 
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been determined for the archaeal[8] and bacterial[9] en-
zymes.[10] All structures confirm that this soluble domain 
forms the catalytic core of the enzyme. The catalytic core is 
composed of an antiparallel β-sheet surrounded by α-heli-
ces, which is characteristic of class II aaRSs.[11] Class-
specific motifs are typically located with sequence motif 1 
building part of the dimer interface and motifs 2 and 3 
recognizing the nucleotide placed at the active site (Figure 2, 
Figure 3, A).  
 The structure of the bacterial PylRStRNAPyl complex 
shows tRNA binding stoichiometry of two tRNAs per en-
zyme dimer[9b] (Figure 2). Each tRNA binds along the surface 
of one of the monomers. Cognate tRNA recognition is en-
sured through interactions with specific nucleotides (i.e. 
identity elements) and core binding surface of the enzyme 
recognizing the characteristic tRNA tertiary structure. The 
top of the acceptor stem (base pair G1:C72 and R73, Figure 2) 
is involved in the critical portion of PylRStRNAPyl interface. 
A concave structure on the enzyme surface sterically 
matches the acceptor helix and directs the tRNAPyl 3′-end 
into the catalytic site. Residues present within this struc-
ture directly communicate with identity elements on 
tRNAPyl: discriminator base (R73) and the first base pair in 
the acceptor stem (G1:C72).[9b,12] Other directly recognized 
residues include D-stem base pairs G10:C25 and A11:U24, 
and G9.[9b,12] 
 The idiosyncratic core of tRNAPyl is recognized domi-
nantly by the elements of one subunit and fewer contacts 
are made with the other monomer. PylRS specific tRNA-
binding domain 1 makes the majority of the interactions 
with the tertiary core of tRNAPyl. The PylRStRNAPyl struc-
ture confirms earlier biochemical data that although bases 
at position 33 and 37 surrounding the anticodon constitute 
identity elements,[13] PylRS does not use the tRNA antico-
don as identity element per se. 
Properties and Engineering of tRNAPyl 
Secondary structures of bacterial and archaeal tRNAPyl are 
remarkably similar, in spite of low sequence similarity.[9b,12] 
Most striking features of tRNAPyl include a prolonged anti-
codon stem (6 bp instead of 5), a tiny D-loop (only 5 bases) 
and the absence of the almost universally conserved 
G18G19 and T54ψ55C56 sequences.[7,9b] It has been pro-
posed that in vivo M. barkeri tRNAPyl is less modified than 
other cellular tRNAs and harbors only 2 modified nucleo-
tides: a 4-thiouridine and a 1-methyl-pseudouridine.[14] 
Structure of D. hafniense tRNAPyl shows that deletion of in-
variant uridine 8 (U8) abolishes the formation of a highly 
conserved tertiary base pair (U8:A14) and leads to unusual 
pairing of G14 with T-loop residue C59. Furthermore, U8 
deletion allows the base on position 9 to flip away from the 
tRNA body. These features of tRNAPyl govern its folding into 
a canonical L-shaped form, but with a very compact core 
that differs from all known canonical tRNA structures.[9b]  
Pyrrolysine 
In nature, Pyl-OTS and Pyl are confined to a small number 
of organisms including methanogenic archaea and some 
bacterial taxa.[15] In these organisms, three consecutive en-
zymes (PylB, PylC and PylD) form a Pyl biosynthesis cluster 
responsible for the transformation of two Lys molecules 
into Pyl.[16] In the first step, PylB, converts Lys to (3R)-me-
thyl-D-ornithine (3MO), which is then ligated to the Nε-
amino group of a second Lys molecule by PylC, giving rise 
 
Figure 2. Structure of the PylRStRNAPyl complex from D. hafniense (PDB ID 2ZNI) from two perspectives. Individual monomers 
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to L-lysine-Nε-(3R)-methyl-D-ornithine. The third enzyme, 
PylD, catalyzes the oxidation of the last intermediate, re-
sulting in the formation of Pyl.[16–17] Pyl is subsequently at-
tached to tRNAPyl by PylRS. In Methanosarcinaceae, 
tRNAPylCUA is a natural suppressor tRNA that decodes a UAG 
stop codon present as an internal stop codon in set of me-
thylamine methyltransferases genes[18] and a tRNAHis 
guanylyltransferase.[19] The incorporation of Pyl in the 
methyltransferase is critical for enzyme catalysis and ena-
bles growth on methylamine as a sole energy source.[20] In 
contrast, in Methanosarcina acetivorans tRNAHis guan-
ylyltransferase the Pyl residue is not essential and can be 
exchanged with Trp without a loss of enzymatic activity.[19] 
PylRS Active Site Architecture  
The PylRS active site contains a large amino acid binding 
pocket where Pyl is mainly recognized through (nonspe-
cific) hydrophobic interactions.[8,21] Secondary carbonyl 
group of Pyl forms hydrogen bonds with Asn-346. A com-
parison of PylRS:Pyl and various PylRS:ncAA complexes[8,22] 
reveals that variations in the ncAA side chain are highly tol-
erated, particularly when they are located in the part of the 
active site responsible for pyrroline recognition.[23] This 
property of PylRS contrasts the general features of aaRSs, 
which are selective against non-cognate substrates. Both 
structural and in vivo studies demonstrate that PylRS can 
use substrates that possess a carbamate, carbonyl or amide 
moiety, which can be positioned to interact with Asn-346 
or Cys-348.  
 The structure of M. mazei PylRS[8,21] shows that Arg-
330 forms a hydrogen bond with the primary carbonyl of 
Pyl and this interaction is seen in complexes with both Pyl 
and Pyl analogs. Most interestingly, the primary amino-
group is not directly recognized but is bound by a water 
molecule (Figure 3, A). This water forms hydrogen bonds 
with amide oxygen of Asp-346 and two backbone amide ni-
trogen atoms of Leu-301 and Ala-302. Because the α-amino 
group of Pyl is loosely recognized, Arg-330 appears to be 
the single residue responsible for the proper orientation of 
Pyl for the nucleophilic attack of the α-phosphate.[8,22a,24] In 
concordance with this flexible mode of α-amino group 
recognition come reports showing acylation of tRNAPyl with 
α-hydroxy acid, D-amino acid and a Nα-methylamino 
acid.[25] Furthermore, it has been reported that several  
α-hydroxy acids can be incorporated into proteins by the 
PylRStRNAPyl o-pair.[26] 
 Although the importance of Asn-346 and other Pyl 
binding residues has been demonstrated through muta-
tional analysis,[22a] there is no coherent kinetic data that 
might disclose the effect of these residues on PylRS amino-
acylation catalysis (Table 1). Steady state parameters for 
Pyl activation have been measured mostly in the absence 
of tRNAPyl, using a ATP-[32P]PPi exchange assay (Table 1). 
Conversely, enzyme-kinetic analyses of PylRS were ham-
pered by the lack of synthetically available Pyl, necessitat-
ing the use of Pyl analog like Nε-((cyclopentyloxy)carbonyl)-
L-lysine more frequently than Pyl. 
 Steady state kinetic parameters with Pyl for full 
length M. mazei PylRS and M. barkeri PylRS show that these 
aaRSs bind the amino acid with a Km of ∼50 μmoldm-3 and 
Figure 3. PylRS topology and α-amino group recognition in 
the active site. The enzyme is composed of two identical 
monomers (grey and magenta) forming a homodimer. 
Characteristic class II aaRS motifs are accentuated: motif 1 
that forms part of the dimer interface is shown in green and 
motif 2 loop (involved in tRNA 3′-CCA recognition) in blue. 
Pyl is bound in the active site and shown in yellow. (Inset) 
Idiosyncratic recognition of the Pyl α-amino group in M. 
mazei PylRS (PDB ID 2ZCE). Instead of directly recognizing 
the α-amino group of the AA substrate PylRS uses a water 
molecule bound to the Asn-346. Water molecule (cyan) is 
shown as a ball. Hydrogen bonds are shown as black dashed 
lines (B) Malleability of the active site as illustrated by 
comparison of the wild-type enzyme and a norbornene 
charging mutant (PDB ID 2Q7H and 4BWA, respectively). 
The wild-type enzyme is shown in magenta and the triple 
Y306G/Y384F/I405R mutant in cyan. Pyl-AMP and 
norbornene-AMP (nonhydrolyzable analogs) are given as 
stick representation in yellow and in green, respectively, 
with transparent surfaces indicating the substrate-binding 
pocket. In the triple mutant the Y306G mutation at the base 
of the AA binding pocket enlarges the binding site thus 
allowing placement of the norbornene head group (this 
space is normally occupied by Tyr-306 side chain, see wild-
type structure). In the wild-type enzyme Asn-346 forms a 
hydrogen bond with the carbonyl-amide linkage of Pyl side 
chain. In contrast, the carbamate linkage of the norbornene 
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kcat of 0.1–0.3 s−1 in ATP-[32P]PPi exchange assay. In the 
presence of tRNAPyl (aminoacylation assay) the affinity for 
the cognate amino acid is improved (20 μmol dm–3), yet  
the kcat remains very low (0.008–0.03 s−1). This kcat value  
is almost 3 orders of magnitude lower than many canonical 
aaRSs. The lower activity may interrelate with the fact  
that Pyl is translated 3000 times less often than a sense  
codon.[22b] 
Amino Acid Substrate Range  
Although low turnover numbers make PylRS a fairly poor 
catalyst in vitro, to date it has been adapted for incorpora-
tion of more than 100 ncAA substrates (full list in).[27] Re-
gardless of the low turnover, in vivo suppression efficiency 
can amount to almost 80 % with engineered enzymes mak-
ing this enzyme a powerful tool for GCE experiments.[28] As 
PylRS can tolerate replacement of the pyrroline ring with a 
similar substituent, more than 20 lysine derivatives were 
reported to be suitable substrates for PylRS without active 
site engineering.[23,27] In addition to lysine derivatives, Pyl-OTS 
can be used to incorporate Phe derivatives[27] although a 
number of Phe derivatives have already been successfully 
incorporated using M. jannaschii and E. coli TyrRS. 
 The lack of specificity towards the functional group 
at the Nε-atom has allowed for incorporation of Lys analogs 
bearing reactive chemical groups that can undergo a selec-
tive reaction with a desired label. Because the label does 
not cross-react with cellular (macro)molecules the reaction 
can occur within a living cell. The earliest reports to intro-
duce a chemical tag via Pyl-OTS included wild-type PylRS. 
Alkyne (1) and azide (2) derivatives (Figure 4) for Cu(I)-cat-
alyzed alkyne–azide triazole-forming reactions (CuAAC, a 
type of reaction commonly referred to as “click chemistry”) 
were introduced into myoglobin as proof-of-principle.[29] 
For the purposes of monitoring conformational changes of 
a protein PylRS was used to install a reactive dye for the 
distance-dependent Förster resonance energy transfer 
(FRET). While the first member of the FRET pair was gener-
ated by alkylation of a Cys residue, alkyne containing Pyl 
analogs (3 and 4, Figure 4) were introduced into calmodulin 
Table 1. Steady-state kinetic parameters for various ncAAs and PylRS enzymes 
Organism ncAA  Km /  mmol dm–3 kcat / s
–1 Assay(a) Enzyme variant(b) Structure
(c) Ref. 
D. hafniense L-pyrrolysine 0.044 0.325 1 PylSc - [6] 
M. barkeri  
Nε-((R)-tetrahydrofuran-2-carbonyl)-L-lysine  0.39 0.062 1 WT - 
[66] 
Nε-(cyclopentanecarbonyl)-L-lysine 5.6 0.04 1 WT - 
L-pyrrolysine 
0.055 0.105 1 WT -  
0.02 0.003 2 WT 2Q7H, 2ZIM, 2ZCE [66] 
Nε-((cyclopentyloxy)carbonyl)-L-lysine 0.55 0.015 1 WT 2Q7G [66] 
L-pyrrolysine 
0.053 n.d. 1 WT 2Q7H, 2ZIM, 2ZCE [23] 
n.d. 0.1 1 WT 2Q7H, 2ZIM 
[6] 
n.d. 0.24 1 Δ92PylS - 
Nε-((cyclopentyloxy)carbonyl)-L-lysine 0.67 n.d. 1 WT 2Q7G [23] 
Nε-acetyl-L-lysine 22.3 0.0341 1 AcKRS3 - [36] 
Nε-D-prolyl-L-lysine 0.5 n.d. 1 WT - [23] 
M. mazei 
3-iodo-L-phenylalanine 0.44 0.0044 2 IFRS 4TQD [22b] 
L-phenylalanine 
21 0.037 1 FRS1 - 
[39a] 14 0.062 1 FRS2 - 
22.8 0.075 1 FRS3 - 
L-pyrrolysine 0.02 0.0083 2 WT 2Q7H, 2ZIM, 2ZCE [22b] 
Nε-acetyl-L-lysine 
35.3 0.0323 1 AcKRS1 4Q6G 
[36] 
7.8 0.00731 1 AcKRS2 - 
(a) (1) - ATP-[32P]PPi exchange 
 (2) - aminoacylation 
(b) AcKRS1- M. mazei PylRS variant L301M/Y306L/L309A/C348F; AcKRS2- M. mazei PylRS variant L301M/L305M/Y306M/C348S; AcKRS3- M. barkeri PylRS variant
L266M/L270I/Y271F/L274A/C313F; FRS1- M. mazei PylRS variant N346A/C348L; FRS2- M. mazei PylRS variant A302L/Y306M/N346S/C348L/Y384L; FRS3- M.
mazei PylRS variant A302F/Y306L/N346T/C348F/Y384L; IFRS- M. mazei PylRS variant N346S/C348I. 
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via SCS strategy and subsequently labelled with azidocou-
marin through a CuAAC reaction.[30]  
 To circumvent inherent cytotoxicity of Cu(I) acti-
vated cyclooctyne derivatives can also be introduced via 
Pyl-OTS. Such compounds can react with azide containing 
labels without additional catalysts. M. mazei PylRS double 
mutant (Y306A/Y384F) was used to introduce transcy-
clooctene (5)[31] and cyclooctyne (6 and 7) derivatives into 
target proteins in E. coli and mammalian cells.[32] Nor-
bornene-bearing ncAA (8) is convenient as it can undergo 
two different types of conjugation: it can be reacted with 
azides (Cu(I) catalysis) or with tetrazines (inverse-electron-
demand Diels–Alder reaction). Human carbonic anhydrase 
II was produced containing norbornene derivatized amino 
acid by using the triple M. mazei PylRS mutant 
(Y306G/Y384F/I405R). Subsequently, norbornene bearing 
sites were exploited for polyethylene glycol (PEG) attach-
ment.[33] When comparing active site architectures (Figure 
3B) it is seen that the mutation of Tyr-306 is critical to en-
large the hydrophobic binding pocket and to accommodate 
bulky head group of norbornene-containing compound. 
 In addition to chemical groups that can render a pro-
tein target susceptible for selective chemistry, many photo-
reactive groups act as substrates for both wild-type PylRS 
and PylRS variants. Photo-reactive ncAAs are attractive; 
they ensure ‘protected’ co-translational incorporation into 
target proteins, and subsequent facile deprotection will 
generate the desired ‘natural’ posttranslational protein 
modifications. An important modified AA, Nε-methyl-L-ly-
sine, cannot be selectively incorporated via Pyl-OTS as it 
lacks the side chain carbonyl-oxygen that is recognized by 
the enzyme. However, protected versions of Nε-methyl-L-
lysine contain carbamate and can serve as substrates for 
PylRS. Upon incorporation they can be deprotected to leave 
Nε-methyl-L-lysine as the incorporated residue (Figure 5). 
 In contrast to Nε-methyl-L-lysine, another important 
lysine posttranslational modification, Nε-acetyl-L-lysine 
(AcK), has been successfully incorporated by an evolved 
PylRS, as the carbonyl oxygen is present in this compound 
and evolved PylRS does not lose its selectivity. Pyl-OTS me-
diated incorporation of AcK has been demonstrated in E. 
coli and mammalian cells. An evolved M. barkeri 
PylRStRNA pair was used to specifically incorporate AcK in 
myoglobin[34] and histones.[35] M. mazei PylRS enzyme was 
also evolved for specific incorporation of AcK and this en-
zyme was later kinetically investigated.[22b,36] Interestingly, 
there are several variants of both M. mazei and M. barkeri 
PylRS that are specific for AcK. It has been proposed that 
the equivalent efficiency of different PylRS variants origi-
nates from the nature of the substrate head group (Table 1). 
Since the acetyl group of AcK is much smaller than pyrroline 
ring of Pyl, mutations in the Pyl binding site need to occupy 
 
 
Figure 4. NcAAs that can be co-translationally incorporated into proteins for bioorthogonal labelling through Cu(I) catalyzed 
cycloaddition (Nε-((prop-2-yn-1-yloxy)carbonyl)-L-lysine (1), Nε-((2-azidoethoxy)carbonyl)-L-lysine (2), Nε-((2R,3S)-3-ethynyl-
tetrahydrofuran-2-carbonyl)-L-lysine (3), Nε-((S)-3-aminohex-5-ynoyl)-L-lysine (4)) or through inverse-electron-demand Diels-
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the vacant space to compensate for the loss of the bulky 
pyrroline ring.[34] 
What is/determines Orthogonality? 
Feasibility of site-specific incorporation of ncAA depends 
on the mutual interaction of host translational machinery 
with the orthogonal aaRStRNA pair. Ideally, the o-tRNA 
would be efficiently recognized by the host elongation fac-
tor and ribosome (Figure 1), but not by the host aaRSs. Con-
versely, o-aaRS should not recognize the host tRNAs or 
charge standard AAs. The conserved tertiary features of 
tRNAs and the relatively low complexity of nucleotide de-
terminants often result in engineered tRNAs that interact 
with the host translation machinery. Attempts to improve 
orthogonality via tRNA engineering often becomes a com-
plex challenge as adding or removing nucleotide determi-
nants can introduce a determinant for another host aaRS. 
 In E. coli, decoding of UGA stop codons with tRNAPyl 
variant leads to high background suppression with Trp[37] 
due to near cognate UGA suppression by E. coli Trp-
tRNATrp.[37a] PylRS and E. coli TrpRS share a number of 
common identity determinants, which affect the cross-
reactivity of tRNAPylUCA. In E. coli, the tRNA anticodon 
positions C34 and A36, as well as G73 act as a minor 
determinant for TrpRS, all of which are present in 
tRNAPylUCA. Mutating the tRNAPylUCA G73 position to U was 
shown to have increased orthogonality.[37a]  
 While natural amber suppressor tRNAPylCUA is orthog-
onal in E. coli, in S. cerevisiae the M. barkeri tRNAPylCUA was 
shown to be the substrate for alanyl-tRNA synthetase 
(AlaRS)[38] due to the presence of a positive identity deter-
minant, G3:U70. Mutation of this base pair to A3:U70 
changed the sequence of the M. barkeri tRNAPyl to that of 
M. mazei tRNAPyl and orthogonality was obtained.[38] 
 In contrast to the known interaction of tRNAPyl with 
the host aaRSs, PylRS shows little to no cross-reactivity with 
the host tRNAs, regardless of the host organism. However, 
a significant challenge for genetic code expansion with 
PylRS is in maintaining orthogonality toward the cellular 
pool of standard AAs. For instance, only 2 active site resi-
dues need to be replaced in PylRS to introduce specificity 
for L-phenylalanine.[39] These active site residues (Asn-346 
 
Figure 5. NcAAs with photo-reactive substituents for photo-crosslinking (Nε-((3-(3-methyl-3H-diazirin-3-yl)propyl)carbamoyl)-L-
lysine (9)) and photo-caged ncAAs (Nε-(tert-butoxycarbonyl)-L-lysine (10), Nε-(tert-butoxycarbonyl)-Nε-methyl-L-lysine (11), 
Nε-((1-(6-nitrobenzo[d][1,3]dioxol-5-yl)ethoxy)carbonyl)-L-lysine (12), Nε-methyl-Nε-(((2-nitrobenzyl)oxy)carbonyl)-L-lysine 
(13), Nε-((benzyloxy)carbonyl)-Nε-methyl-L-lysine (14), Nε-((allyloxy)carbonyl)-Nε-methyl-L-lysine (15)). NcAAs for chemical 
ligation purposes (2S)-2,6-diamino-5-mercaptohexanoic acid (16). NcAAs that can be synthesized in E. coli using the pylBCD
biosynthetic cluster: Nε-((R)-3,4-dihydro-2H-pyrrole-2-carbonyl)-L-lysine (17), Nε-((R)-3,4-dihydro-2H-pyrrole-2-carbonyl)-L-
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or Cys-348) are frequently targets of randomization in di-
rected evolution experiments as they bind the carbamate 
of Pyl or the ncAA substrate.[39]  
Examples of Applications 
In mammals and other eukaryotes protein-protein interac-
tions and posttranslational modifications play crucial roles 
in regulating the function of proteins. Transient protein-
protein interactions can be explored in vivo by using photo-
active ncAA crosslinkers. Photo-inducible crosslinkers such 
as p-benzoyl-L-phenylalanine (pBpa) have been used exten-
sively and were mostly incorporated via Tyr-OTS.[1a,40] Pyl-
OTS incorporated (3-(3-methyl-3H-diazirin-3-yl)-propa-
mino-carbonyl-Nε-L-lysine (DiZPK, 9) has the advantage 
over pBpa because of its flexibility and length and has been 
incorporated via Pyl-OTS into proteins in bacteria, yeast 
and mammalian cells.[41]  
 Novel ways of studying posttranslational modifica-
tions in mammalian cell lines have been explored by intro-
ducing photo-caged AAs into proteins. Incorporation of 
these AA derivatives with the Pyl-OTS has allowed for a 
number of investigations that aimed to distinguish how AA 
modifications influence the behaviour of proteins in vivo. 
Wild-type PylRS utilizes some of the Boc-protected lysine 
derivatives without the need for engineering of the enzyme 
active site. For example, the ncAAs Nε-(tert-butoxycar-
bonyl)-L-lysine (10) and Nε-(tert-butoxycarbonyl)-Nε-me-
thyl-L-lysine (11) have been incorporated with further 
deprotection resulting in proteins containing  Nε-methyl-
ated Lys-residues.[29,42] To specifically charge the photo-
caged lysine derivative (12) a variant of the M. barkeri PylRS 
has been selected for through directed evolution. This 
PylRStRNAPylCUA pair was used to introduce a critical lysine 
residue into a kinase MEK1, in a photo-caged state. As the 
kinase is a part of the signalling pathway, a cellular network 
could be activated by light irradiation and subsequent re-
lease of the caging group.[43] An evolved version of M. bark-
eri was used to introduce a photo-caged version of Tyr into 
a STAT1 protein (a part of the interferon mediated signal 
transduction network) thus enabling studies of Tyr phos-
phorylation in vivo.[44]  
 Using the SCS strategy for the incorporation of lysine 
derivatives into histone proteins has allowed for novel ap-
proaches to gain insight into the role of histone posttrans-
lational modifications. Using the Pyl-OTS, ncAAs 10 and 11 
were introduced into histone H3 and employed to generate 
Nε, Nε-dimethyl-L-lysine containing H3 proteins. After ncAA 
insertion and protein isolation, the recombinant histone 
was subjected to a number of chemical modification steps 
that enabled methylation on the previously protected site. 
This approach was undertaken to circumvent the inability 
of wild-type PylRS to activate Nε, Nε-dimethyl-L-lysine and 
the lack of specificity of evolved variants of this enzyme.[42] 
Accordingly, a monomethylated lysine residue (Nε-methyl-
L-lysine) was introduced in the photocaged state (13) into 
myoglobin by a heterologous Pyl o-pair (M. barkeri PylRS 
and M. mazei tRNA) and the system was shown to be func-
tional in both E. coli and mammalian cells.[45] That and a 
similar photocaged version of monomethylated lysine (14) 
were synthesized and introduced into green fluorescence 
protein (GFP) and Z domain protein. Here, the decaging 
process included UV photolysis (13) or hydrogenation 
(14).[46] A similar approach was utilized on a separate occa-
sion, in this case by using the M. mazei enzyme, where a 
Pyl-OTS was evolved to facilitate Nε-((allyloxy)carbonyl)-
Nε-methyl-L-lysine (15) incorporation in bacteria; this AA 
can be converted to Nε-methyl-L-lysine with a ruthenium 
catalyst.[46]  
 In addition to introducing posttranslational modifi-
cations by decaging translated ncAAs, very large moieties 
can be incorporated by exploiting native chemical ligation 
strategy. The strategy involves a thiol group in the first pro-
tein that can attack a C-terminal thioester of a second pro-
tein. As 1,2-aminothiols can react with thioesters to form 
an amide bond, ncAA δ-thiol-L-lysine (16) was introduced 
by Pyl-OTS for protein ubiquitination.[47] The protein con-
taining 16 was then reacted with an ubiquitin thioester and, 
after desulfurization of the complex, ubiquitin conjugates 
were isolated. 
 The challenge of incorporating ncAAs in multicellular 
organisms was first achieved by using Pyl-OTS in C. ele-
gans.[48] tRNAPyl was used to decode amber stop codon and 
introduce Nε-(tert-butoxycarbonyl)-L-lysine (10) and Nε-
((prop-2-yn-1-yloxy)carbonyl)-L-lysine (1). Since ncAA con-
taining protein was produced from stop codon containing 
transcripts, nonsense mediated decay pathway that targets 
transcripts with internal termination codons for destruc-
tion had to be circumvented. This was achieved by using a 
smg2 knockout strain, where product of smg2 gene is a 
component of the NMD pathway.[49] 
 In D. melanogaster, genetic code expansion was also 
achieved using Pyl-OTS. Site-specifically labeled proteins 
were produced containing Nε-((bicyclo[2.2.1]hept-5-en-2-
ylmethoxy)carbonyl)-L-lysine (8) reacted with a tetrazine 
probe.[50] Moreover, same ncAA was stochastically incorpo-
rated into proteins in specific tissues and at specific times. 
This was achieved by crossing flies that expressed Pyl-OTS 
and a gene of interest with flies expressing Gal4 in specific 
tis sues and at specific times. Transcriptional activator Gal4 
is expressed using a tissue-specific promoter and, when 
present, activates the expression of transgenes under GAL4 
upstream activating sequences (Gal4 UAS). Both pylS and 
the gene of interest with an internal stop codon were 
placed under Gal4 UAS and in this manner site-specific in-
corporation of ncAA was enabled only when Gal4 was pre-
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 While the incorporation of ncAAs into proteins with 
the Pyl-OTS has been extensively reported in eukaryotes, 
one notable exception has been yeast, where there have 
been only two reports of Pyl-OTS use in S. cerevisiae for 
proof-of-principle and optimization purposes. To date Pyl-
OTS has not been used in any yeast species other than S. 
cerevisiae. The first reported use of the Pyl-OTS in yeast uti-
lized the M. mazei PylRS and M. mazei tRNAPyl pair.[51] The 
authors used a M. mazei PylRS variant that had been se-
lected for in E. coli to utilize Nε-(tert-butyloxycarbonyl)-L-ly-
sine (10). Using a screen where a variant of the 
transcription activator Gal4 containing two stop codons in 
its coding sequence is used to drive expression of reporter 
genes, resulting in phenotypes that allow for both positive 
and negative selection.[3a] A weak phenotype dependent on 
the presence of the ncAA was observed, demonstrating 
both the orthogonality and function of the M. mazei 
PylRStRNAPyl pair in S. cerevisiae. Although a weak pheno-
type was observed, a reporter protein was not isolated and 
the ncAA incorporation was not confirmed through MS, 
making it difficult to assess the efficiency of incorporation. 
Further work to characterize and optimize the Pyl-OTS 
in S. cerevisiae successfully utilized the M. barkeri PylRSM. 
mazei tRNAPyl pair and derivatives for the incorporation of 
several lysine analogs.[38] Initially, the authors used the M. 
barkeri PylRSM. barkeri tRNAPyl pair, which had successfully 
been used in other organisms;[40] however, due to a lack of 
orthogonality the M. barkeri tRNAPyl was mutated to that of 
M. mazei tRNAPyl. Expression of the tRNAPyl was a challenge 
and the use of external RNA polymerase III promoters that 
have been effective in heterologous tRNA expression in yeast 
did not produce sufficient amounts of functional tRNAPyl for 
effective suppression. This was overcome through engineer-
ing of the yeast dicistronic tRNA operon encoding tRNAArg 
and tRNAAsp, where the two mature tRNAs are produced 
from a dimeric precursor RNA.[52] In this instance the tRNAAsp 
was replaced by the gene for tRNAPyl and both tRNA genes 
transcribed from the internal promoter of the tRNAArg gene. 
Using the M. mazei tRNAPyl with variants of M. barkeri PylRS 
resulted Gal4 read-through based phenotypes dependent on 
the required ncAA. While incorporation was confirmed for 3 
of the 5 analogs utilized, the yields of reporter protein ob-
tained (30-100 µg/L) were nearly two orders of magnitude 
below what can be obtained with other ncAAs and orthog-
onal pairs in yeast.[53] 
 While only two studies have been reported, it is clear 
that both expression and orthogonality tRNAPyl is different 
in yeast when compared to other eukaryotic cells. The dis-
tinct challenges of using this OTS in yeast in conjunction 
with the known low solubility of PylRS in other organisms 
and the low activity of PylRS and variants toward ncAAs 
combined likely account for the low incorporation 
efficiency observed with this orthogonal pair in yeast. 
OUTLOOK 
New Routes to Pyl 
A complete understanding of kinetic features of the Pyl-OTS 
is still lacking due to the difficult nature of Pyl chemical syn-
thesis. The first reported chemical synthesis of Pyl involved 
coupling of (4R,5R)-4-methylpyrroline-5-carboxylic acid to 
lysine.[54] During synthesis, the sensitive carboxypyrroline 
ring is exposed to strong acidic conditions, which may be 
responsible for pyrroline ring degradation and low Pyl 
yields. To avoid this, an alternative synthetic route was de-
veloped where Pyl was synthesized with the generation of 
the pyrroline ring occurring in the penultimate step of the 
synthesis which resulted in a 2 times higher yield of Pyl.[55] 
 An appealing alternative to chemical synthesis is the 
transplantation of the Pyl biosynthetic cluster to E. coli for 
Pyl producing purposes. Because Pyl is synthesized from 
Lys, no additional amino acid is needed to be supplemented 
in the culture media. This strategy was used to produce Pyl 
containing proteins in E. coli, as Pyl-OTS can to be co-trans-
formed in the same strain.[56] Interestingly, supplementing 
culture medium with D-ornithine results with the produc-
tion of pyrroline-carboxy-lysine (Pcl, 17) instead of Pyl. Fur-
thermore, different 3′-substituted D-ornithine derivatives 
(3MO analogs) can be added to create Pyl analogs with the 
help of incomplete Pyl biosynthetic cluster.[57] Only genes 
for PylC and PylD are needed to produce Pyl, if 3MO or 3MO 
analog is added. For this reason, adding D-ornithine or (3S)-
ethynyl-D-ornithine to the media results with desmethyl-
pyrrolysine (dmPyl, 18) and ethynyl-pyrrolysine production 
(ePyl, 19). Although the production of Pyl analogs was 
streamlined for amber suppression and incorporation,[57] 
manipulating Pyl biosynthetic cluster opens new perspec-
tives on intracellular ncAA production. 
Stop Codon Suppression vs. Sense  
Codon Reassignment 
In-frame stop codons targeted for ncAA incorporation in a 
gene of interest are not the only such stop codons in a tran-
scriptome of a model organism (with the exception of re-
coded E. coli strains)[1b,58] as the same codons occur as 
natural stop codons in a variety of host’s cellular proteins. 
Decoding such sites with the aid of introduced o-pair may 
have deleterious consequences as illustrated by the Sep-
OTS in E. coli[59] or Pyl-OTS in certain mammalian cell 
lines.[60] In E. coli, natural stop codons are not equally sus-
ceptible to o-tRNA mediated decoding and this susceptibil-
ity depends upon the presence of the appropriate release 
factor and/or introduction of ribosomal proteins with lower 
affinity for the same release factor.[61] In mammalian cell 
lines, transcriptional response to amber suppression varies 
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over a 1000 genes dysregulated after introducing Pyl-OTS 
(or a derivative AcKRS-OTS) into mouse embryonic stem 
cells and only 11 in mouse embryonic fibroblast.[60] 
 Apart from the toxic effect that a suppressor tRNA 
may exert on cellular fitness, protein production via SCS 
suffers from variable yields as a consequence of the com-
petition between the suppressor tRNA and the cellular re-
lease factors for binding to the same stop codon. This 
problem is partially alleviated by using strains with release 
factor deletions.[58] An alternative to using a release factor 
deletion strain is to target sense codons. As PylRS does not 
recognize the tRNA anticodon, any sense codon can be tar-
geted for ncAA incorporation by Pyl-OTS. Sense codon re-
assignment was previously attempted in Mycoplasma 
capricolum. As this organism’s genome contains only 6 in-
stances of the CGG (arginine) codon and lacks the corre-
sponding tRNAArgCCG, this codon was considered to be an 
“open” sense codon. Unfortunately, engineered tRNAPylCCG 
was shown not to be orthogonal in this organism as it was 
recognized by M. capricolum ArgRS.[62] This problem was 
circumvented in E. coli by introducing serine and leucine 
anticodons into tRNAPyl.[28] As neither the E. coli LeuRS or 
SerRS use the tRNA anticodon as a recognition element, 
these enzymes do not cross-react with tRNAPylCAG or 
tRNAPylACU, resulting in orthogonal tRNAPyl variants that are 
able to decode sense codons. Using the M. mazei PylRS IFRS 
variant, which aminoacylates 3-iodo-L-phenylalanine (3-I-
Phe), it was possible to quantify incorporation at targeted 
Ser AGU codons. The extent of 3-I-Phe incorporation at the 
targeted site in a GFP reporter protein was ~65 %.[28] The 
fact that the efficient IFRS can, in part, accomplish 
reassigning a high-frequency serine codon[28] opens new 
opportunities for using this enzyme as an integral part of E. 
coli translation machinery. 
 Another strategy to utilize sense codons for GCE 
purposes consists in targeting the degenerate codons that 
occur in the genome at a low frequency (rare codons) and 
are decoded by a low abundance tRNA isoacceptor. The 
approach requires elimination of the host’s dedicated 
tRNA and the synonymous replacement of targeted co-
dons within the genome (at least in essential genes). Re-
cently, a critical step toward successful emancipation of 
the rare AUA (Ile) codon was achieved by introducing My-
coplasma mobile tRNAIleUAU into E. coli. M. mobile 
tRNAIleUAU is able to translate AUA codons without modi-
fication of its anticodon while E. coli tRNAIle2CAU depends 
on tRNAIle-lysidine synthetase (encoded by tilS) to modify 
its C34 to 2-lysyl-cytidine for proper decoding of rare AUA 
codons. As M. mobile tRNA can rescue the lethal tilS dele-
tion through direct AUA codon reading it is now possible 
to introduce an orthogonal IleRS and reassign the AUA co-
don with a desired ncAA.[63] Successful reassignment of a  
rare Arg codon (AGG) was also achieved in E. coli with M. 
mazei PylRStRNAPylCCU.[64] In opposition to rare AUA co-
dons, AGG codons are recognized by 2 native tRNAs, 
tRNAArg4UCU (translates both AGA and AGG codons) and 
the low abundance tRNAArg5CCU (devoted only to AGG de-
coding). Although tRNAArg5CCU is dispensable in E. coli, 
tRNAArg4UCU is required to decode AGA codons; however, 
the levels of tRNAArg4UCU needed to be reduced to avoid 
wobble decoding of AGG codons and enable preferential 
reading by the orthogonal tRNAPylCCU. By using a modified 
version of tRNAArg4UCU placed under a weak promotor, the 
authors succeeded in reassigning the rare AGG codon 
from arginine to L-homoarginine which was introduced 
using an engineered version of M. mazei PylRS and 
tRNAPylCCU.[64b] Sense codon reassignment offers the excit-
ing possibility introducing artificial amino acids through-
out the organism’s proteome.  
Is Orthogonality Impairing 
Functionality? 
Although unusual tRNAPyl structure helps maintain orthog-
onality to host aaRSs and tRNAs, ncAA-tRNAPyl still has to be 
efficiently recognized by the host elongation factor and the 
ribosome. It was recently recognized that tRNAPyl might not 
be an optimal substrate for the bacterial EF-Tu. Improved 
tRNAPyl binding was achieved through mutagenesis of nu-
cleotides in the acceptor and T-stems (which are expected 
to interact with elongation factor).[65] When using the opti-
mized version of tRNAPyl (tRNAPyl-opt) the authors were 
able to show increased multiple AcK incorporation into 
three different proteins by an engineered PylRS variant. In 
vitro kinetic measurements with PylRS variants showed 
that tRNAPyl-opt is basically undistinguishable from wild-
type tRNAPyl thus inferring that the improved suppression 
efficiency of tRNAPyl-opt originates from its improved inter-
action with EF-Tu. 
 
CONCLUSION 
The Pyl-OTS is a powerful tool for genetic code expansion. 
To a large extent this rests on the astonishing polyspecific-
ity of the enzyme toward ncAAs and the orthogonality of 
Pyl-OTS in the majority of common host organisms. While 
biochemical and structural studies have aided in our under-
standing of Pyl and ncAA binding, a thorough kinetic analy-
sis is still lacking due to the limited availability (through 
chemical synthesis) of Pyl and the unexplored possibility of 
large scale preparation of Pyl from in vivo sources. As 
shown above, the Pyl-OTS offers a robust methodology for 
ncAA incorporation, and it has been widely applied. How-
ever, much still remains to be discovered to really make the 
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